Home >> Tag Archives: Natera—

Tag Archives: Natera—

Natera selected for ctDNA study, 12/17

December 2017—Natera announced a second research collaboration with Denmark’s Aarhus University utilizing the company’s research use only technology to evaluate ctDNA as a useful biomarker for detecting minimal residual disease, treatment response, and disease recurrence in colorectal cancer patients. (The university will also use the Signatera technology in a bladder cancer study.)

Read More »